A Chinese biotechnology company focusing on the discovery and development of innovative therapeutics for serious musculoskeletal diseases globally.
Employees: 1-10
Investors 2
Date | Name | Website |
- | OrbiMed | orbimed.co... |
- | 3H Health ... | 3hhinvestm... |
Mentions in press and media 2
Date | Title | Description | Source |
26.10.2023 | Deals in brief: YouTrip secures Series B funding, Kopital Ve... | YouTrip secures USD 50 million in Series B funding The Singapore-based fintech company has secured U... | kr-asia.co... |
25.10.2023 | Angitia Biopharma snags $46m and 48 more Greater China deals... | Biotech firm Angitia Biopharmaceuticals has snagged $46 million in a Series B extension round led by... | dealstreet... |